Biagi, M <br/><br/>
Activity of Imipenem-Relebactam and Meropenem-Vaborbactam against Carbapenem-Resistant, SME-Producing Serratia marcescens.  [electronic resource] 

 -  Antimicrobial agents and chemotherapy  03 2020 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1098-6596 
<br/><br/><label>Standard No.: </label>10.1128/AAC.02255-19  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anti-Bacterial Agents--pharmacology<br/>Azabicyclo Compounds--pharmacology<br/>Bacterial Proteins--genetics<br/>Boronic Acids--pharmacology<br/>Carbapenem-Resistant Enterobacteriaceae--drug effects<br/>Ceftazidime--pharmacology<br/>Drug Combinations<br/>Drug Resistance, Multiple, Bacterial--drug effects<br/>Humans<br/>Imipenem--pharmacology<br/>Meropenem--pharmacology<br/>Microbial Sensitivity Tests<br/>Serratia Infections--microbiology<br/>Serratia marcescens--drug effects<br/>beta-Lactamase Inhibitors--pharmacology<br/>beta-Lactamases--genetics